Listen now
Key takeaways
- Many MedTech startups fail due to poor customer adoption, stemming from inadequate commercialization strategies, rather than product deficiencies.
- Commercialization is an 'art' requiring a holistic roadmap that integrates and extends beyond individual sales and marketing plans.
- Cybersecurity is a critical, non-negotiable component of regulatory affairs and commercialization, acting as essential insurance against malicious actors.
- Effective selling employs 'emotional persuasion dialogue' to help customers rationalize purchases, moving beyond simple product feature presentations.
- The 'move fast and break things' approach is generally unsuitable for most industries, especially MedTech, often leading to hastiness and failure.
- Regulatory bodies, including the FDA, increasingly mandate cybersecurity as a core element for medical device approval and market access.
- The primary concern in medical device cybersecurity is patient harm, with data breaches being a secondary, albeit important, consideration.
What are the 10 essential components of a successful commercialization plan in the MedTech industry, and why are they often overlooked?
This episode explores the critical role of commercialization in the MedTech industry. The conversation explores the reasons behind the high failure rate of MedTech startups and emphasizes the importance of a comprehensive commercialization plan, cybersecurity considerations, and the pursuit of wisdom over speed.
Today’s guest is Craig T. Ingram, a MedTech and healthcare technology consultant who helps companies avoid going broke by focusing on effective commercialization strategies. Craig is the Chief Commercialization Strategy and Growth Advisor for Int'l Commercialization Growth Partners.
Key points:
(3:21) The Commercialization Roadmap
-
Many companies lack a written commercialization roadmap, focusing instead on sales and marketing plans.
-
Key components of commercialization include regulatory affairs, product design, production, and alliances and partnerships, which are often overlooked.
(10:11) Cybersecurity
-
Cybersecurity is not evil but a critical necessity, similar to insurance, to protect against malicious activity and data breaches.
-
Cybersecurity can be viewed as a means of preventing malicious activity rather than just protecting data.
(24:51) Value vs Expertise
-
Many manufacturers struggle to evaluate cybersecurity vendors, often prioritizing cost over specialized expertise.
-
Applying the same commercialization strategies as large companies is ineffective for startups and small to medium-sized enterprises.
(34:20) Wisdom vs. Speed in Business
-
The "move fast and break things" mentality prevalent in Silicon Valley can be detrimental to proper commercialization.
-
Effective commercialization requires a focus on getting it right rather than being right, and a willingness to learn and adapt.
Notable quotes
“Nine out of ten companies do not have a commercialization roadmap or plan. They have a business plan. They may have a sales plan. They may have a marketing plan. But the sales plans and the marketing plans fit into an overall commercialization plan.”
“Cybersecurity, relatively speaking, is an inexpensive insurance to prevent somebody from breaking into your company's data house and stealing something that's not theirs.”
“Cybersecurity is your armed guard to take care of your data home.”
“From a regulatory affairs standpoint, cybersecurity fits right in to commercialization component number three, and that's regulatory.”
Frequently asked questions
Bring this work to your device
Need help with fda premarket cybersecurity?
Blue Goat Cyber delivers fda premarket cybersecurity services for medical device manufacturers - from threat modeling to FDA-ready reports.
FDA Premarket Cybersecurity ServicesMore on FDA Premarket Cybersecurity
Keep listening
-
Episode 70
Why MedTech Needs Specialists with Zoltan Kevei and Saby Toth of Bishop & Co
With Zoltan Kevei
-
Episode 69
Science Before Hype in MedTech Investing with Varun Turlapati of Chaanakya Capital
With Varun Turlapati
-
Episode 67
De-Risking Product Decisions in MedTech Startups with Brent Lavin of Ironwood MedTech Partners
With Brent Lavin
-
Episode 65
Who Owns Patient Data Security in Trials with Rob Bedford, CEO of Franklyn Health
With Rob Bedford